Amanda A. Bouffard

2.4k total citations · 2 hit papers
29 papers, 1.6k citations indexed

About

Amanda A. Bouffard is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Amanda A. Bouffard has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Amanda A. Bouffard's work include CAR-T cell therapy research (29 papers), CRISPR and Genetic Engineering (7 papers) and Nanowire Synthesis and Applications (6 papers). Amanda A. Bouffard is often cited by papers focused on CAR-T cell therapy research (29 papers), CRISPR and Genetic Engineering (7 papers) and Nanowire Synthesis and Applications (6 papers). Amanda A. Bouffard collaborates with scholars based in United States, Denmark and Germany. Amanda A. Bouffard's co-authors include Marcela V. Maus, Rebecca C. Larson, Irene Scarfò, Andrea Schmidts, Ana P. Castaño, Mark B. Leick, Matthew J. Frigault, Bryan D. Choi, Stefanie R. Bailey and Bob S. Carter and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Amanda A. Bouffard

25 papers receiving 1.5k citations

Hit Papers

CAR-T cells secreting BiTEs circumvent antigen escape wit... 2019 2026 2021 2023 2019 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
    2019 426 citations Bryan D. Choi, Xiaoling Yu et al. Nature Biotechnology profile →
  2. CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
    2022 225 citations Rebecca C. Larson, Michael C. Kann et al. Nature profile →

Peers

Amanda A. Bouffard
Dongrui Wang United States
Andrea Schmidts United States
Dayenne G. van Leeuwen United States
Mythili Koneru United States
Ignazio Caruana Italy
Jamie R. Wagner United States
Selene Nuñez-Cruz United States
Paula L. Kosasih United States
Mark B. Leick United States
Donald R. Shaffer United States
Dongrui Wang United States
Amanda A. Bouffard
Citations per year, relative to Amanda A. Bouffard Amanda A. Bouffard (= 1×) peers Dongrui Wang

Countries citing papers authored by Amanda A. Bouffard

Since Specialization
Citations

This map shows the geographic impact of Amanda A. Bouffard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda A. Bouffard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda A. Bouffard more than expected).

Fields of papers citing papers by Amanda A. Bouffard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda A. Bouffard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda A. Bouffard. The network helps show where Amanda A. Bouffard may publish in the future.

Co-authorship network of co-authors of Amanda A. Bouffard

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda A. Bouffard. A scholar is included among the top collaborators of Amanda A. Bouffard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda A. Bouffard. Amanda A. Bouffard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouffard, Amanda A., Mark B. Leick, Nicholas J. Haradhvala, et al.. (2025). On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical models. Nature Communications. 16(1). 9650–9650.
2.
Park, Sangwoo, Christine Ho, Eli P. Darnell, et al.. (2025). Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. Nature Communications. 16(1). 11246–11246.
3.
Salas‐Benito, Diego, Sangwoo Park, Christine Ho, et al.. (2025). Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a time. Journal for ImmunoTherapy of Cancer. 13(9). e012822–e012822.
4.
Grauwet, Korneel, Trisha R. Berger, Michael C. Kann, et al.. (2024). Stealth transgenes enable CAR-T cells to evade host immune responses. Journal for ImmunoTherapy of Cancer. 12(5). e008417–e008417. 8 indexed citations
5.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2024). Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics. Science Translational Medicine. 16(750). eadk7640–eadk7640. 14 indexed citations
6.
Silva, Harrison, Marc Wehrli, Michael C. Kann, et al.. (2024). CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML. Blood. 145(7). 720–731. 11 indexed citations
7.
Larson, Rebecca C., Michael C. Kann, Charlotte Graham, et al.. (2023). Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. Nature Communications. 14(1). 7509–7509. 23 indexed citations
8.
Kann, Michael C., Emily M. Schneider, Amanda A. Bouffard, et al.. (2023). Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7. Leukemia. 38(3). 590–600. 4 indexed citations
9.
Kembuan, Gabriele, Michael C. Kann, William M. Lin, et al.. (2023). Genetic retargeting of E3 ligases to enhance CAR T cell therapy. Cell chemical biology. 31(2). 338–348.e5. 7 indexed citations
10.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2023). Abstract 4098: Chimeric antigen receptor (CAR) T cells overexpressing Bcl-xL increase proliferation and antitumor activity alone and in combination with BH3 mimetics. Cancer Research. 83(7_Supplement). 4098–4098. 3 indexed citations
11.
Larson, Rebecca C., Michael C. Kann, Stefanie R. Bailey, et al.. (2022). CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours. Nature. 604(7906). 563–570. 225 indexed citations breakdown →
12.
Leick, Mark B., Harrison Silva, Irene Scarfò, et al.. (2022). Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. 40(5). 494–508.e5. 88 indexed citations
13.
Jan, Max, Irene Scarfò, Rebecca C. Larson, et al.. (2021). Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Science Translational Medicine. 13(575). 180 indexed citations
14.
Schmidts, Andrea, Amanda A. Bouffard, Angela C. Boroughs, et al.. (2020). Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. Journal for ImmunoTherapy of Cancer. 8(2). e000990–e000990. 18 indexed citations
15.
Larson, Rebecca C., Ana P. Castaño, Amanda A. Bouffard, et al.. (2020). Bispecific CAR T cells for multiple myeloma: natural ligand compared to tandem scFv design. The Journal of Immunology. 204(1_Supplement). 246.3–246.3. 3 indexed citations
16.
Schmidts, Andrea, Maria Ormhøj, Bryan D. Choi, et al.. (2019). Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances. 3(21). 3248–3260. 85 indexed citations
17.
Choi, Bryan D., Xiaoling Yu, Ana P. Castaño, et al.. (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nature Biotechnology. 37(9). 1049–1058. 426 indexed citations breakdown →
18.
Boroughs, Angela C., Rebecca C. Larson, Bryan D. Choi, et al.. (2019). Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. JCI Insight. 4(8). 104 indexed citations
19.
Choi, Bryan D., Xiaoling Yu, Ana P. Castaño, et al.. (2019). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. Journal for ImmunoTherapy of Cancer. 7(1). 304–304. 228 indexed citations
20.
Scarfò, Irene, Maria Ormhøj, Matthew J. Frigault, et al.. (2018). Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas. Blood. 132(14). 1495–1506. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongrui Wang Breakdown of academic impact, for papers by Andrea Schmidts Breakdown of academic impact, for papers by Dayenne G. van Leeuwen Breakdown of academic impact, for papers by Mythili Koneru Breakdown of academic impact, for papers by Ignazio Caruana Breakdown of academic impact, for papers by Jamie R. Wagner Breakdown of academic impact, for papers by Selene Nuñez-Cruz Breakdown of academic impact, for papers by Paula L. Kosasih Breakdown of academic impact, for papers by Mark B. Leick Breakdown of academic impact, for papers by Donald R. Shaffer
Rankless by CCL
2026